We are live on ! Find out more
FBB

Fulton Breakefield Broenniman Portfolio holdings

AUM $1.53B
1-Year Est. Return 18.11%
This Fund
S&P 500
This Quarter Est. Return
+0.76%
1 Year Est. Return
+18.11%
3 Year Est. Return
+57.23%
5 Year Est. Return
+68.56%
10 Year Est. Return
+240.26%
AUM
$341M
AUM Growth
Cap. Flow
+$345M
Cap. Flow %
101.26%
Top 10 Hldgs %
19.59%
Holding
132
New
132
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7.42M
2
VZ icon
Verizon
VZ
+$6.96M
3
GE icon
GE Aerospace
GE
+$6.92M
4
IBM icon
IBM
IBM
+$6.91M
5
JNJ icon
Johnson & Johnson
JNJ
+$6.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 10.5%
2 Consumer Staples 10.3%
3 Consumer Discretionary 10.14%
4 Industrials 8.94%
5 Energy 8.6%

Similar funds

Fulton Breakefield Broenniman's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Fulton Breakefield Broenniman, which disclosed 132 positions worth $341M. Its ten largest holdings account for 20% of the portfolio.

Its largest position is Pfizer: 268,454 shares worth $7.13M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, followed by Consumer Staples and Consumer Discretionary.

  • Fulton Breakefield Broenniman's largest Q2 2013 buy was Pfizer: 268,454 shares worth $7.13M.
  • Fulton Breakefield Broenniman's ten largest holdings make up 20% of its $341M portfolio in Q2 2013.
  • Fulton Breakefield Broenniman disclosed 132 positions in Q2 2013, its first 13F filing on record.

Based on Fulton Breakefield Broenniman's 13F filing for Q2 2013, filed 7 Aug 2013.